Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.63 -0.01 (-2.02%)
As of: Sep 30, 2026 · 3:47 PM EDT

Biodexa Pharmaceuticals (BDRX) Total Non-Current Liabilities (2013 - 2026)

Updated

Biodexa Pharmaceuticals (BDRX) reported Total Non-Current Liabilities of $444,096 for the quarter ended Jun 30, 2026, down 63.4% from $1.21 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Biodexa Pharmaceuticals posted Total Non-Current Liabilities of $850,439, down 53.3% from the prior year.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 43.2% (years ended Dec 2020 to Dec 2025).
  • By year, Total Non-Current Liabilities came in at $1.82 million in the year ended Dec 31, 2024 (+396.1%), $366,928 in the year ended Dec 31, 2023 (-36.0%), $573,013 in the year ended Dec 31, 2022 (-32.8%) and $853,045 in the year ended Dec 31, 2021 (+503.9%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Total Non-Current Liabilities since the quarter ended Dec 31, 2023.
  • Year over year, Total Non-Current Liabilities gained in 1 of the last four quarters, with growth averaging 59.3%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was the quarter ended Dec 31, 2021 (growth of 475.4%); the low point was the quarter ended Jun 30, 2026 (a decline of 63.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn - 444,095.58
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 444,095.58
Dec 31, 2025 857,957.20
Jun 30, 2025 1.21 Mn
Dec 31, 2024 1.83 Mn
Jun 30, 2024 2.22 Mn
Dec 31, 2023 366,139.81
Jun 30, 2023 475,518.00
Dec 31, 2022 543,065.81
Jun 30, 2022 687,585.56
Dec 31, 2021 835,766.58
Jun 30, 2021 953,250.67
Dec 31, 2020 145,249.61
Jun 30, 2020 132,861.43
Dec 31, 2019 7.29 Mn
Jun 30, 2019 492,657.73
Dec 31, 2018 1.35 Mn
Jun 30, 2018 8.39 Mn
Dec 31, 2017 8.21 Mn
Jun 30, 2017 1.56 Mn
Dec 31, 2016 2.01 Mn
API Access

Biodexa Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BDRX&period=max&api_key=YOUR_API_KEY